Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Cytotoxic T-Cell Immunity to Influenza

McMichael, A. J., Gotch, F. M., Noble, G. R., & Beare, P. A. (1983) · New England Journal of Medicine · doi:10.1056/nejm198307073090103 · Cited by 931 · see citing works

Helping the CD8+ T-cell response

Bevan, M. J. (2004) · Nature reviews. Immunology · doi:10.1038/nri1413 · Cited by 790 · see citing works

The Critical Need for CD4 Help in Maintaining Effective Cytotoxic T Lymphocyte Responses

Kalams, S. A., & Walker, B. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2199 · Cited by 660 · see citing works

Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10

Sun, J., Madan, R., Karp, C. L., & Braciale, T. J. (2009) · Nature Medicine · doi:10.1038/nm.1929 · Cited by 616 · see citing works

Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009

Shinde, V., Bridges, C. B., Uyeki, T. M., Shu, B., Balish, A. L., Xu, X., Lindstrom, S., Gubareva, L. V., Deyde, V., Garten, R. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903812 · Cited by 606 · see citing works

Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus

Kash, J. C., Tumpey, T. M., Proll, S. C., Carter, V., Perwitasari, O., Thomas, M. J., Basler, C. F., Palese, P., Taubenberger, J. K., García-Sastre, A., et al. (2006) · Nature · doi:10.1038/nature05181 · Cited by 551 · see citing works

CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help

Nakanishi, Y., Lu, B., Gerard, C. J., & Iwasaki, A. (2009) · Nature · doi:10.1038/nature08511 · Cited by 545 · see citing works

Characterization of CD4+ CTLs Ex Vivo

Appay, V., Zaunders, J. J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P., Grey, P., Smith, D. E., McMichael, A. J., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5954 · Cited by 545 · see citing works

T Cell Responses to Whole SARS Coronavirus in Humans

Li, C. K., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 499 · see citing works

CD8+ T cells clear influenza virus by perforin or Fas-dependent processes

Topham, D. J., Tripp, R. A., & Doherty, P. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5197 · Cited by 486 · see citing works

Emerging Infections: Pandemic Influenza

Glezen, W. P. (1996) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a017917 · Cited by 462 · see citing works

A question of self‐preservation: immunopathology in influenza virus infection

Gruta, N. L. L., Kedzierska, K., Stambas, J., & Doherty, P. C. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100026 · Cited by 454 · see citing works

Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals

Lee, L. Y.-H., Do, L. A. H., Simmons, C. P., de Jong, M. D., Châu, N. V. V., Schumacher, R., Peng, Y. C., McMichael, A. J., Farrar, J., Smith, G. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32460 · Cited by 423 · see citing works

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

Casazza, J. P., Betts, M. R., Price, D. A., Precopio, M., Ruff, L. E., Brenchley, J. M., Hill, B. J., Roederer, M., Douek, D. C., & Koup, R. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052246 · Cited by 338 · see citing works

Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites

Both, G. W., Sleigh, M. J., Cox, N. J., & Kendal, A. P. (1983) · Journal of Virology · doi:10.1128/jvi.48.1.52-60.1983 · Cited by 327 · see citing works

Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection

Shin, H., Blackburn, S. D., Blattman, J. N., & Wherry, E. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061937 · Cited by 273 · see citing works

Influenza Vaccine — Outmaneuvering Antigenic Shift and Drift

Treanor, J. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp038238 · Cited by 261 · see citing works

Error thresholds and the constraints to RNA virus evolution

Holmes, E. C. (2003) · Trends in Microbiology · doi:10.1016/j.tim.2003.10.006 · Cited by 254 · see citing works

The Origins of Pandemic Influenza — Lessons from the 1918 Virus

Belshe, R. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058281 · Cited by 235 · see citing works

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice

Kreijtz, J. H. C. M., Bodewes, R., van Amerongen, G., Kuiken, T., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.08.036 · Cited by 229 · see citing works

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes

Yang, O. O., Kalams, S. A., Rosenzweig, M., Piechocka‐Trocha, A., Jones, N. G., Koziel, M. J., Walker, B. D., & Johnson, R. P. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5799-5806.1996 · Cited by 217 · see citing works

Cytotoxic T Lymphocyte Antigen 4 (CTLA4) Blockade Accelerates the Acute Rejection of Cardiac Allografts in CD28-deficient Mice: CTLA4 Can Function Independently of CD28

Lin, H., Rathmell, J. C., Gray, G. S., Thompson, C. B., Leiden, J. M., & Alegre, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.199 · Cited by 182 · see citing works

Healthy Human Subjects Have CD4+ T Cells Directed against H5N1 Influenza Virus

Roti, M., Yang, J., Berger, D., Huston, L., James, E. A., & Kwok, W. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1758 · Cited by 130 · see citing works

Cytotoxic human CD4+ T cells

van de Berg, P. J., van Leeuwen, E. M. M., ten Berge, I. J. M., & van Lier, R. A. W. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.007 · Cited by 129 · see citing works

Epidemiological Characteristics of 2009 (H1N1) Pandemic Influenza Based on Paired Sera from a Longitudinal Community Cohort Study

Riley, S., Kwok, K. O., Wu, K. M., Ning, D. Y., Cowling, B. J., Wu, J. T. K., Ho, L., Tsang, T., Lo, S., Chu, D. K. W., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000442 · Cited by 108 · see citing works

The Natural Viral Load Profile of Patients With Pandemic 2009 Influenza A(H1N1) and the Effect of Oseltamivir Treatment

Li, I. W. S., Hung, I. F., To, K. K., Chan, K., Wong, S. S. Y., Chan, J. F., Cheng, V. C., Tsang, O. T.-Y., Lai, S.-T., Lau, Y., et al. (2010) · CHEST Journal · doi:10.1378/chest.09-3072 · Cited by 105 · see citing works

Assessment of Seasonal Influenza A Virus-Specific CD4 T-Cell Responses to 2009 Pandemic H1N1 Swine-Origin Influenza A Virus

Ge, X., Tan, V., Bollyky, P. L., Standifer, N. E., James, E. A., & Kwok, W. W. (2010) · Journal of Virology · doi:10.1128/jvi.02226-09 · Cited by 101 · see citing works

Cutting Edge: CD4 T Cells Generated from Encounter with Seasonal Influenza Viruses and Vaccines Have Broad Protein Specificity and Can Directly Recognize Naturally Generated Epitopes Derived from the Live Pandemic H1N1 Virus

Richards, K. A., Topham, D. J., Chaves, F. A., & Sant, A. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001395 · Cited by 79 · see citing works

Hallmarks of CD4 T cell immunity against influenza

McKinstry, K. K., Strutt, T. M., & Swain, S. L. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02367.x · Cited by 79 · see citing works

Correlates of protection: Novel generations of influenza vaccines

Rimmelzwaan, G. F., & McElhaney, J. E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.043 · Cited by 78 · see citing works

An overview of serum antibody responses to influenza virus antigens.

Couch, R. B. (2003) · PubMed · Cited by 68 · see citing works

Killer T cells in influenza.

Stambas, J., Guillonneau, C., Kedzierska, K., Mintern, J., Doherty, P., & Gruta, N. L. L. (2008) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2008.08.007 · Cited by 46 · see citing works

Reassortment between human A(H3N2) viruses is an important evolutionary mechanism

Schweiger, B., Bruns, L., & Meixenberger, K. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.105 · Cited by 44 · see citing works

Memory T-Cell Response to Rotavirus Detected with a Gamma Interferon Enzyme-Linked Immunospot Assay

Kaufhold, R. M., Field, J. A., Caulfield, M. J., Wang, S., Joseph, H., Wooters, M. A., Green, T., Clark, H. F., Krah, D. L., & Smith, J. G. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5684-5694.2005 · Cited by 36 · see citing works

Surveillance and impact of influenza in Europe

Aymard, M., Valette, M., Lina, B., & Thouvenot, D. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00103-6 · Cited by 23 · see citing works

Epidemiology and Virology of Influenza Illness

Monto, A. S. (2000) · The American Journal of Managed Care · Cited by 22 · see citing works

Clinical and laboratory diagnosis of influenza virus infections.

Newton, D. W., Treanor, J. J., & Menegus, M. A. (2000) · PubMed · Cited by 21 · see citing works

Identification of T-Cell Epitopes Using ELISpot and Peptide Pool Arrays

Tobery, T. W., & Caulfield, M. J. (2004) · Humana Press eBooks · doi:10.1385/1-59259-679-7:121 · Cited by 20 · see citing works

Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent

Belshe, R. B., & Mendelman, P. M. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(03)00098-5 · Cited by 19 · see citing works

Intraseasonal Dynamics and Dominant Sequences in H3N2 Influenza

Creanza, N., Schwarz, J. S., & Cohen, J. E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008544 · Cited by 12 · see citing works

Plaque Formation with Influenza Viruses in Dog Kidney Cells

Ho, P. P. K., Young, A. L., & Truehaft, M. (1976) · Journal of General Virology · doi:10.1099/0022-1317-33-1-143 · Cited by 10 · see citing works

Would you volunteer to be quarantined and infected with influenza virus?

OXFORD, J. S., Gelder, C. M., & Lambkin‐Williams, R. (2005) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.3.1.1 · Cited by 9 · see citing works

Epidemiology and virology of influenza illness. Based on a presentation by Arnold S. Monto, MD.

(2000) · PubMed · Cited by 9 · see citing works

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · see citing works

Adaptive immunity to SARS-CoV-2 and COVID-19

Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860 · see citing works

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works

Influenza

Krammer, F., Smith, G. J. D., Fouchier, R. A. M., Peiris, M. J. S., Kedzierska, K., Doherty, P. C., Palese, P., Shaw, M. L., Treanor, J. J., Webster, R. G., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0002-y · Cited by 1,589 · see citing works

Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509 · see citing works

The T cell immune response against SARS-CoV-2

Moss, P. A. H. (2022) · Nature Immunology · doi:10.1038/s41590-021-01122-w · Cited by 1,205 · see citing works

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179 · see citing works

T cells in health and disease

Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,057 · see citing works

Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia

Lin, L., Lu, L., Cao, W., & Li, T. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1746199 · Cited by 909 · see citing works

Human memory T cells: generation, compartmentalization and homeostasis

Farber, D. L., Yudanin, N. A., & Restifo, N. P. (2014) · Nature Reviews Immunology · doi:10.1038/nri3567 · Cited by 897 · see citing works

Cellular immune correlates of protection against symptomatic pandemic influenza

Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., & Lalvani, A. (2013) · Nature Medicine · doi:10.1038/nm.3350 · Cited by 862 · see citing works

Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals

Tarke, A., Sidney, J., Methot, N., Yu, E. D., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., Wang, E., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100355 · Cited by 706 · see citing works

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582 · see citing works

Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses

Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496 · see citing works

COVID-19 Coronavirus Vaccine Design Using Reverse Vaccinology and Machine Learning

Ong, E., Wong, M. U., Huffman, A., & He, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01581 · Cited by 499 · see citing works

Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting

Gostic, K. M., Ambrose, M. R., Worobey, M., & Lloyd‐Smith, J. O. (2016) · Science · doi:10.1126/science.aag1322 · Cited by 464 · see citing works

Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection

Petsch, B., Schnee, M., Vogel, A. B., Lange, E., Hoffmann, B., Voss, D., Schlake, T., Thess, A., Kallen, K.-J., Stitz, L., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2436 · Cited by 461 · see citing works

Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells

Hombrink, P., Helbig, C., Backer, R. A., Piet, B., Oja, A. E., Stark, R., Brasser, G., Jongejan, A., Jonkers, R. E., Nota, B., et al. (2016) · Nature Immunology · doi:10.1038/ni.3589 · Cited by 455 · see citing works

Vaccine-generated lung tissue–resident memory T cells provide heterosubtypic protection to influenza infection

Zens, K. D., Chen, J. K., & Färber, D. L. (2016) · JCI Insight · doi:10.1172/jci.insight.85832 · Cited by 415 · see citing works

Influenza Virus: Dealing with a Drifting and Shifting Pathogen

Kim, H., Webster, R. G., & Webby, R. J. (2018) · Viral Immunology · doi:10.1089/vim.2017.0141 · Cited by 423 · see citing works

Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease

Zhao, Y., Qin, L., Zhang, P., Li, K., Liang, L., Sun, J., Xu, B., Dai, Y., Li, X., Zhang, C., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.139834 · Cited by 402 · see citing works

Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany

Streeck, H., Schulte, B., Kümmerer, B. M., Richter, E., Höller, T., Fuhrmann, C., Bartok, E., Dolscheid‐Pommerich, R., Berger, M., Wessendorf, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19509-y · Cited by 391 · see citing works

The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis

Yang, Z., Liu, J., Zhou, Y., Zhao, Q., Zhao, Q., & Liu, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.062 · Cited by 361 · see citing works

Heterogeneity of Human CD4 ⁺ T Cells Against Microbes

Sallusto, F. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112056 · Cited by 336 · see citing works

Next-generation influenza vaccines: opportunities and challenges

Wei, C., Crank, M. C., Shiver, J. W., Graham, B. S., Mascola, J. R., & Nabel, G. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0056-x · Cited by 333 · see citing works

The history of MF59 ® adjuvant: a phoenix that arose from the ashes

O’Hagan, D. T., Ott, G. S., Nest, G. V., Rappuoli, R., & Giudice, G. D. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.140 · Cited by 318 · see citing works

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett, J. R., Belij-Rammerstorfer, S., Dold, C., Ewer, K. J., Folegatti, P. M., Gilbride, C., Halkerston, R., Hill, J., Jenkin, D., Stockdale, L., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-01179-4 · Cited by 315 · see citing works

Current and next generation influenza vaccines: Formulation and production strategies

Soema, P. C., Kompier, R., Amorij, J., & Kersten, G. F. A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.05.023 · Cited by 315 · see citing works

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

Jóźwik, A., Habibi, M. S., Paras, A., Zhu, J., Guvenel, A., Dhariwal, J., Almond, M., Wong, E., Sykes, A., Maybeno, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10224 · Cited by 303 · see citing works

Integrative Physiology of Pneumonia

Quinton, L. J., Walkey, A. J., & Mizgerd, J. P. (2018) · Physiological Reviews · doi:10.1152/physrev.00032.2017 · Cited by 308 · see citing works

Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease

Goldblatt, D., Alter, G., Crotty, S., & Plotkin, S. A. (2022) · Immunological Reviews · doi:10.1111/imr.13091 · Cited by 300 · see citing works

Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms

Lynn, D. J., Benson, S. C., Lynn, M. A., & Pulendran, B. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00554-7 · Cited by 300 · see citing works

Mucosal immune responses to infection and vaccination in the respiratory tract

Mettelman, R. C., Allen, E. K., & Thomas, P. G. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.013 · Cited by 272 · see citing works

Immunological memory to SARS‐CoV ‐2 infection and COVID ‐19 vaccines

Sette, A., & Crotty, S. (2022) · Immunological Reviews · doi:10.1111/imr.13089 · Cited by 266 · see citing works

Natural T Cell–mediated Protection Against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study

Hayward, A. C., Wang, L., Goonetilleke, N. P., Fragaszy, E., Bermingham, A., Copas, A. J., Dukes, O., Millett, E. R. C., Nazareth, I., Nguyen‐Van‐Tam, J. S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-1988oc · Cited by 266 · see citing works

Adjuvanted influenza vaccines

Tregoning, J. S., Russell, R. F., & Kinnear, E. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1415684 · Cited by 263 · see citing works

Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells

Wang, Z., Wan, Y., Qiu, C., Quiñones‐Parra, S. M., Zhu, Z., Loh, L., Tian, D., Ren, Y., Hu, Y., Zhang, X., et al. (2015) · Nature Communications · doi:10.1038/ncomms7833 · Cited by 262 · see citing works

Cross-reactive memory T cells and herd immunity to SARS-CoV-2

Lipsitch, M., Grad, Y. H., Sette, A., & Crotty, S. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00460-4 · Cited by 260 · see citing works

Immunosenescence: influenza vaccination and the elderly

Haq, K., & McElhaney, J. E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.008 · Cited by 256 · see citing works

Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses

van de Sandt, C. E., Kreijtz, J. H. C. M., & Rimmelzwaan, G. F. (2012) · Viruses · doi:10.3390/v4091438 · Cited by 242 · see citing works

Complex Correlates of Protection After Vaccination

Plotkin, S. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit048 · Cited by 239 · see citing works

Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens

Knudsen, N. P. H., Olsen, A. W., Buonsanti, C., Follmann, F., Zhang, Y., Coler, R. N., Fox, C. B., Meinke, A. L., D’Oro, U., Casini, D., et al. (2016) · Scientific Reports · doi:10.1038/srep19570 · Cited by 234 · see citing works

SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8 + T cell activation in COVID-19 patients

Saini, S. K., Hersby, D. S., Tamhane, T., Povlsen, H. R., Hernandez, S. P. A., Nielsen, M., Gang, A. O., & Hadrup, S. R. (2021) · Science Immunology · doi:10.1126/sciimmunol.abf7550 · Cited by 222 · see citing works

Lung Airway-Surveilling CXCR3hi Memory CD8+ T Cells Are Critical for Protection against Influenza A Virus

Slütter, B., Pewe, L. L., Kaech, S. M., & Harty, J. T. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.013 · Cited by 228 · see citing works

Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms

McKinstry, K. K., Strutt, T. M., Kuang, Y., Brown, D. M., Sell, S., Dutton, R. W., & Swain, S. L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63689 · Cited by 223 · see citing works

Erratum: RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

Jóźwik, A., Habibi, M. S., Paras, A., Zhu, J., Guvenel, A., Dhariwal, J., Almond, M., Wong, E., Sykes, A., Maybeno, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11011 · Cited by 223 · see citing works

T Cell Responses to Viral Infections – Opportunities for Peptide Vaccination

Huber, S. K. R., van Beek, J., de Jonge, J., Luytjes, W., & van Baarle, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00171 · Cited by 221 · see citing works

Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern

(2021) · doi:10.1038/s41467-021-25167-5 · Cited by 216 · see citing works

Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.

Skelly, D. T., Harding, A. C., Gilbert-Jaramillo, J., Knight, M. L., Longet, S., Brown, A., Adele, S., Adland, E., Brown, H., Team, M. L., et al. (2021) · doi:10.21203/rs.3.rs-226857/v2 · Cited by 216 · see citing works

Tissue-resident CD4 + T helper cells assist the development of protective respiratory B and CD8 + T cell memory responses

Son, Y. M., Cheon, I. S., Wu, Y., Li, C., Wang, Z., Gao, X., Chen, Y., Takahashi, Y., Fu, Y., Dent, A. L., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abb6852 · Cited by 210 · see citing works

Correlates of protection to influenza virus, where do we go from here?

Cox, R. J. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22908 · Cited by 209 · see citing works

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines

Sridhar, S., Brokstad, K. A., & Cox, R. J. (2015) · Vaccines · doi:10.3390/vaccines3020373 · Cited by 209 · see citing works

Cytotoxic CD4 T Cells—Friend or Foe during Viral Infection?

Juno, J. A., van Bockel, D., Kent, S. J., Kelleher, A. D., Zaunders, J. J., & Munier, C. M. L. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00019 · Cited by 195 · see citing works

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

Fendler, A., de Vries, E. G. E., GeurtsvanKessel, C. H., Haanen, J. B. A. G., Wormann, B. J., Turajlic, S., & von Lilienfeld‐Toal, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00610-8 · Cited by 205 · see citing works

Immunology and efficacy of MF59-adjuvanted vaccines

Ko, E., & Kang, S. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1495301 · Cited by 198 · see citing works

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

Antrobus, R., Coughlan, L., Berthoud, T. K., Dicks, M. D. J., Hill, A. V. S., Lambe, T., & Gilbert, S. C. (2013) · Molecular Therapy · doi:10.1038/mt.2013.284 · Cited by 197 · see citing works

Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials

Ward, B. J., Makarkov, A. I., Séguin, A., Pillet, S., Trépanier, S., Dhaliwall, J. K., Libman, M., Vesikari, T., & Landry, N. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32014-6 · Cited by 192 · see citing works

Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 Influenza a virus: Obese/Overweight Response to Influenza

Paich, H. A., Sheridan, P. A., Handy, J., Karlsson, E. A., Schultz-Cherry, S., Hudgens, M. G., Noah, T. L., Weir, S. S., & Beck, M. A. (2013) · Obesity · doi:10.1002/oby.20383 · Cited by 184 · see citing works

T Cell Responses to SARS-CoV-2

Sette, A., Sidney, J., & Crotty, S. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101721-061120 · Cited by 181 · see citing works

Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community

Ip, D., Lau, L. L., Leung, N., Fang, V. J., Chan, K., Chu, D. K. W., Leung, G. M., Peiris, M. J. S., Uyeki, T. M., & Cowling, B. J. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw841 · Cited by 186 · see citing works

Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques

Jegaskanda, S., Weinfurter, J. T., Friedrich, T. C., & Kent, S. J. (2013) · Journal of Virology · doi:10.1128/jvi.03030-12 · Cited by 184 · see citing works

A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2

Woods, C. W., McClain, M. T., Chen, M., Zaas, A. K., Nicholson, B. P., Varkey, J. B., Veldman, T., Kingsmore, S. F., Huang, Y., Lambkin‐Williams, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052198 · Cited by 185 · see citing works

Revealing the role of CD4+ T cells in viral immunity

Sant, A. J., & McMichael, A. J. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20121517 · Cited by 181 · see citing works

Immune responses after live attenuated influenza vaccination

Mohn, K. G.-I., Smith, I., Sjursen, H., & Cox, R. J. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1377376 · Cited by 179 · see citing works

Mucosal Immune Responses Predict Clinical Outcomes during Influenza Infection Independently of Age and Viral Load

Oshansky, C. M., Gartland, A. J., Wong, S., Jeevan, T., Wang, D., Roddam, P. L., Caniza, M. A., Hertz, T., DeVincenzo, J. P., Webby, R. J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1616oc · Cited by 173 · see citing works

Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly

Pereira, B. I., Xu, X., & Akbar, A. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583019 · Cited by 182 · see citing works

Neutrophils-related host factors associated with severe disease and fatality in patients with influenza infection

Tang, B. M. P., Shojaei, M., Teoh, S., Meyers, A. F. A., Ho, J., Ball, T. B., Keynan, Y., Pisipati, A., Kumar, A., Eisen, D. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11249-y · Cited by 176 · see citing works

Experimental infection of human volunteers

Roestenberg, M., Hoogerwerf, M.-A., Ferreira, D. M., Mordmüller, B. G., & Yazdanbakhsh, M. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30177-4 · Cited by 167 · see citing works

Pathogenicity and virulence of influenza

Liang, Y. (2023) · Virulence · doi:10.1080/21505594.2023.2223057 · Cited by 187 · see citing works

Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination

Jansen, J. M., Gerlach, T. H., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019) · Journal of Clinical Virology · doi:10.1016/j.jcv.2019.08.009 · Cited by 168 · see citing works

Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells

Herati, R. S., Muselman, A., Vella, L., Bengsch, B., Parkhouse, K., Del Alcazar, D., Kotzin, J., Doyle, S. A., Tebas, P., Hensley, S. E., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aag2152 · Cited by 167 · see citing works

The immune response to influenza in older humans: beyond immune senescence

McElhaney, J. E., Verschoor, C. P., Andrew, M. K., Haynes, L., Kuchel, G. A., & Pawelec, G. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00181-1 · Cited by 168 · see citing works

The Era of Cytotoxic CD4 T Cells

Cenerenti, M., Saillard, M., Romero, P. J., & Jandus, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.867189 · Cited by 167 · see citing works

Updates on immunologic correlates of vaccine-induced protection

Plotkin, S. A. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.10.046 · Cited by 165 · see citing works

T cell mediated immunity to influenza: mechanisms of viral control

Gruta, N. L. L., & Turner, S. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.06.004 · Cited by 164 · see citing works

Universal Vaccines and Vaccine Platforms to Protect against Influenza Viruses in Humans and Agriculture

Rajão, D. S., & Perez, D. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00123 · Cited by 160 · see citing works

SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties

Watson, A., Madsen, J., & Clark, H. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.622598 · Cited by 159 · see citing works

Immunological assessment of influenza vaccines and immune correlates of protection

Reber, A., & Katz, J. M. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.35 · Cited by 157 · see citing works

T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals

Bilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf7517 · Cited by 147 · see citing works

Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin

Brazzoli, M., Magini, D., Bonci, A., Buccato, S., Giovani, C., Kratzer, R., Zurli, V., Mangiavacchi, S., Casini, D., Brito, L. M., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01786-15 · Cited by 154 · see citing works

Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study

Memoli, M. J., Czajkowski, L. M., Reed, S., Athota, R., Bristol, T., Proudfoot, K., Fargis, S., Stein, M. K., Dunfee, R. L., Shaw, P. A., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu924 · Cited by 153 · see citing works

Antiviral B cell and T cell immunity in the lungs

Chiu, C., & Openshaw, P. (2014) · Nature Immunology · doi:10.1038/ni.3056 · Cited by 151 · see citing works

The impact of CMV infection on survival in older humans

Pawelec, G., McElhaney, J. E., Aiello, A. E., & Derhovanessian, E. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.04.002 · Cited by 145 · see citing works

Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity

Laidlaw, B. J., Decman, V., Ali, M. A., Abt, M. C., Wolf, A. I., Monticelli, L. A., Mozdzanowska, K., Angelosanto, J., Artis, D., Erikson, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003207 · Cited by 141 · see citing works

A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults

Pillet, S., Aubin, É., Trépanier, S., Bussière, D., Dargis, M., Poulin, J., Yassine‐Diab, B., Ward, B. J., & Landry, N. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.03.008 · Cited by 144 · see citing works

Dysregulation of Antiviral Function of CD8+ T Cells in the Chronic Obstructive Pulmonary Disease Lung: Role of the PD-1–PD-L1 Axis

McKendry, R., Spalluto, C. M., Burke, H., Nicholas, B., Cellura, D., Al‐Shamkhani, A., Staples, K. J., & Wilkinson, T. M. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0782oc · Cited by 144 · see citing works

Better influenza vaccines: an industry perspective

Chen, J.-R., Liu, Y.-M., Tseng, Y.-C., & Ma, C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-0626-6 · Cited by 143 · see citing works

Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium

Pachnio, A., Ciaúrriz, M., Begum, J., Lal, N., Zuo, J., Beggs, A. D., & Moss, P. A. H. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005832 · Cited by 141 · see citing works

Virus-specific T cells as correlate of (cross-)protective immunity against influenza

Altenburg, A. F., Rimmelzwaan, G. F., & de Vries, R. D. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.11.054 · Cited by 140 · see citing works

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics

Lindeboom, R. G. H., Worlock, K. B., Dratva, L. M., Yoshida, M., Scobie, D., Wagstaffe, H. R., Richardson, L., Wilbrey-Clark, A., Barnes, J. L., Kretschmer, L., et al. (2024) · Nature · doi:10.1038/s41586-024-07575-x · Cited by 143 · see citing works

T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines

McElhaney, J. E., Kuchel, G. A., Zhou, X., Swain, S. L., & Haynes, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00041 · Cited by 138 · see citing works

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults

Coughlan, L., Sridhar, S., Payne, R., Edmans, M. D., Milicic, A., Venkatraman, N., Lugonja, B., Clifton, L., Qi, C., Folegatti, P. M., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.02.011 · Cited by 138 · see citing works

Assessment of Influenza Virus Hemagglutinin Stalk-Based Immunity in Ferrets

Krammer, F., Hai, R., Yondola, M. A., Tan, G. S., Leyva-Grado, V. H., Ryder, A. B., Miller, M. S., Rose, J. K., Palese, P., García‐Sastre, A., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03004-13 · Cited by 134 · see citing works

Exploiting Mucosal Immunity for Antiviral Vaccines

Iwasaki, A. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112315 · Cited by 132 · see citing works

Design, recruitment, and microbiological considerations in human challenge studies

Darton, T. C., Blohmke, C. J., Moorthy, V. S., Altmann, D. M., Hayden, F. G., Clutterbuck, E. A., Levine, M. M., Hill, A. V. S., & Pollard, A. J. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00068-7 · Cited by 130 · see citing works

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

Altenburg, A. F., Kreijtz, J. H. C. M., de Vries, R. D., Song, F., Fux, R., Rimmelzwaan, G. F., Sutter, G., & Volz, A. (2014) · Viruses · doi:10.3390/v6072735 · Cited by 126 · see citing works

A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Chen, J., Wang, P., Yuan, L., Zhang, L., Zhang, L., Zhao, H. J., Chen, C., Chen, Y., Han, J., Jia, J., et al. (2022) · 中国科学通报：英文版 · doi:10.1016/j.scib.2022.05.018 · Cited by 130 · see citing works

Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Green, C., Scarselli, E., Sande, C., Thompson, A., de Lara, C. M., Taylor, K., Haworth, K., Sorbo, M. D., Angus, B., Siani, L., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5745 · Cited by 129 · see citing works

Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis

Lee, J. K. H., Lam, G., Shin, T., Samson, S., Greenberg, D. P., & Chit, A. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.09.004 · Cited by 129 · see citing works

The roles of resident, central and effector memory CD 4 T‐cells in protective immunity following infection or vaccination

Gray, J. I., Westerhof, L. M., & MacLeod, M. K. L. (2018) · Immunology · doi:10.1111/imm.12929 · Cited by 128 · see citing works

Memory T cell responses in influenza A infection and vaccination in humans

Chui, C. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · doi:10.5287/ora-no78adaw7

The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza

DiPiazza, A. T., Richards, K. A., Knowlden, Z. A. G., Nayak, J. L., & Sant, A. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00010 · Cited by 42 · see citing works

The Way Forward: Potentiating Protective Immunity to Novel and Pandemic Influenza Through Engagement of Memory CD4 T Cells

Sant, A. J. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy666 · Cited by 12 · see citing works

1061The Role of CD4 T Cell Mediated Immunity in Pandemic Influenza Protection

Nayak, J. L., Sant, A. J., & Alam, S. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu052.769

Distinct and complementary roles of CD4 T cells in protective immunity to influenza virus

Sant, A. J., Richards, K. A., & Nayak, J. L. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.019 · Cited by 47 · see citing works